why am i not losing weight on semaglutide compounds your loss may be optimal with 🤔 Why do some people lose a lot of weight with GLP-1 drugs… while others don't? A new Nature study (~28,000 patients) Why Am I Not Losing

Peptides AOD-9604 Metabolic Modulation

It typically dissipates within 30 to 60 minutes as the tirzepatide spreads through the tissue

[2] This new program blends trusted nutrition coaching with modern medical treatments, aiming to provide the best of both worlds: science-backed prescriptions and long-term lifestyle support for sustainable results

Animal Research Context: Scaling from Rodents Preclinical studies with Dihexa and angiotensin IV analogues employed doses that ranged considerably depending on species, route, and outcome measured: Intravenous (IV) Administration Animal studies using intravenous dosing (which bypasses absorption barriers and achieves near-complete bioavailability) reported cognitive and neuroprotective effects at: 0.1 to 2.0 mg/kg in rodent studies (McCoy et al., 2013) Doses at the higher end of this range (12 mg/kg IV) produced robust behavioral effects For a 70 kg human, equivalent to 70140 mg total IV dose (crude extrapolation) However, direct extrapolation from rodents to humans is unreliable due to differences in metabolism, brain penetration, and receptor sensitivity Intraperitoneal (IP) Administration IP dosing (injection into the abdominal cavity, with slower absorption than IV) showed effects at: Up to 10 mg/kg in some studies Lower bioavailability than IV, requiring higher nominal doses for similar effects This route is not practical for human use Why Rodent Dosing Doesn't Directly Translate Rodent pharmacokinetics differ substantially from humans